Anika Therapeutics Inc (ANIK)
25.42
-0.12
(-0.47%)
USD |
NASDAQ |
Mar 28, 16:00
25.38
-0.04
(-0.16%)
After-Hours: 20:00
Anika Therapeutics Net Income (Quarterly): -63.00M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -63.00M |
September 30, 2023 | -6.576M |
June 30, 2023 | -2.741M |
March 31, 2023 | -10.35M |
December 31, 2022 | -4.908M |
September 30, 2022 | -4.175M |
June 30, 2022 | -2.843M |
March 31, 2022 | -2.933M |
December 31, 2021 | -5.793M |
September 30, 2021 | 0.558M |
June 30, 2021 | 6.531M |
March 31, 2021 | 2.838M |
December 31, 2020 | -15.66M |
September 30, 2020 | -6.411M |
June 30, 2020 | -7.708M |
March 31, 2020 | 5.793M |
December 31, 2019 | 4.051M |
September 30, 2019 | 9.20M |
June 30, 2019 | 9.435M |
March 31, 2019 | 4.507M |
December 31, 2018 | 7.718M |
September 30, 2018 | 7.599M |
June 30, 2018 | 10.09M |
March 31, 2018 | -6.686M |
December 31, 2017 | 8.067M |
Date | Value |
---|---|
September 30, 2017 | 6.887M |
June 30, 2017 | 11.37M |
March 31, 2017 | 5.493M |
December 31, 2016 | 8.085M |
September 30, 2016 | 8.952M |
June 30, 2016 | 8.615M |
March 31, 2016 | 6.895M |
December 31, 2015 | 11.04M |
September 30, 2015 | 8.38M |
June 30, 2015 | 7.819M |
March 31, 2015 | 3.516M |
December 31, 2014 | 7.816M |
September 30, 2014 | 6.171M |
June 30, 2014 | 9.302M |
March 31, 2014 | 15.03M |
December 31, 2013 | 6.655M |
September 30, 2013 | 4.957M |
June 30, 2013 | 5.895M |
March 31, 2013 | 3.068M |
December 31, 2012 | 4.463M |
September 30, 2012 | 1.645M |
June 30, 2012 | 3.737M |
March 31, 2012 | 1.912M |
December 31, 2011 | 2.883M |
September 30, 2011 | 2.976M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-63.00M
Minimum
Dec 2023
9.435M
Maximum
Jun 2019
-4.509M
Average
-2.888M
Median
Net Income (Quarterly) Benchmarks
The Cooper Companies Inc | 81.20M |
Staar Surgical Co | 7.756M |
OrthoPediatrics Corp | -6.691M |
NexGel Inc | -0.55M |
Innovative Eyewear Inc | -1.551M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 42.97M |
Total Expenses (Quarterly) | 44.56M |
EPS Diluted (Quarterly) | -4.30 |
Enterprise Value | 304.62M |
Gross Profit Margin (Quarterly) | 61.27% |
Profit Margin (Quarterly) | -146.6% |
Earnings Yield | -22.23% |
Normalized Earnings Yield | -22.23 |